Bliss GVS Pharma
Bliss GVS Pharma Share Price Chart
Bliss GVS Pharma last traded at ₹668.00 (2026-10-13). Over the past month the stock moved -5.0%, three months the stock moved +75.3%, year the stock moved +343.7%. Its closing range over 52 weeks is ₹128.10 – ₹737.60, with the latest close 9.4% below the high.
Closing prices up to 2026-10-13.
About Bliss GVS Pharma
Incorporated in 1984, Bliss GVS Pharma Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups.
Change of Promoter[1] [2] In May 2026, the company disclosed that certain promoter and non-promoter shareholders had entered into a Share Purchase Agreement with Anupam Rasayan India Ltd for the proposed acquisition of approximately 43.28% of its paid-up equity share capital for Rs. 1,369 Cr, subject to regulatory approvals and other closing conditions. The transaction also triggered a mandatory open offer for up to an additional 26% stake from public shareholders.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Bliss GVS Pharma reported sales of ₹286.00 crore (+38.2%) and net profit of ₹51.00 crore (+15.9%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 286.00 | 76.00 | 27.00 | 51.00 | 4.72 |
| Mar 2026 | 257.00 | 44.00 | 17.00 | 37.00 | 3.36 |
| Dec 2025 | 218.00 | 35.00 | 16.00 | 25.00 | 2.20 |
| Sep 2025 | 244.00 | 43.00 | 18.00 | 29.00 | 2.58 |
| Jun 2025 | 207.00 | 41.00 | 20.00 | 44.00 | 4.08 |
| Mar 2025 | 198.00 | 21.00 | 11.00 | 17.00 | 1.47 |
| Dec 2024 | 210.00 | 30.00 | 14.00 | 26.00 | 2.26 |
| Sep 2024 | 218.00 | 41.00 | 19.00 | 26.00 | 2.31 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +2.8% | +4.5% | +0.0% | +12.5% | +11.9% | +3.8% | +29.8% | +38.2% |
| Operating profit growth | -24.1% | -31.8% | -25.0% | +20.6% | +4.9% | +16.7% | +109.5% | +85.4% |
| Net profit growth | -39.5% | -10.3% | – | +100.0% | +11.5% | -3.8% | +117.6% | +15.9% |
| EPS growth | -43.0% | -14.4% | – | +107.1% | +11.7% | -2.7% | +128.6% | +15.7% |
| OPM % | 19.0% | 14.0% | 11.0% | 20.0% | 18.0% | 16.0% | 17.0% | 27.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Bliss GVS Pharma reported sales of ₹927.00 crore (+14.4%) and net profit of ₹135.00 crore (+50.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 927.00 | 164.00 | 18.00 | 135.00 | 12.21 |
| Mar 2025 | 810.00 | 127.00 | 16.00 | 90.00 | 8.00 |
| Mar 2024 | 770.00 | 151.00 | 20.00 | 82.00 | 7.21 |
| Mar 2023 | 752.00 | 117.00 | 16.00 | 77.00 | 6.80 |
| Mar 2022 | 747.00 | 118.00 | 16.00 | 23.00 | 1.45 |
| Mar 2021 | 577.00 | 107.00 | 18.00 | 74.00 | 6.64 |
| Mar 2020 | 689.00 | 123.00 | 18.00 | 95.00 | 9.43 |
| Mar 2019 | 899.00 | 160.00 | 18.00 | 127.00 | 11.99 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +10.3% | -23.4% | -16.3% | +29.5% | +0.7% | +2.4% | +5.2% | +14.4% |
| Operating profit growth | -18.8% | -23.1% | -13.0% | +10.3% | -0.8% | +29.1% | -15.9% | +29.1% |
| Net profit growth | +42.7% | -25.2% | -22.1% | -68.9% | +234.8% | +6.5% | +9.8% | +50.0% |
| EPS growth | +110.4% | -21.4% | -29.6% | -78.2% | +369.0% | +6.0% | +11.0% | +52.6% |
| OPM % | 18.0% | 18.0% | 18.0% | 16.0% | 16.0% | 20.0% | 16.0% | 18.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Bliss GVS Pharma.
Get Free AI Stock Analysis FREE →Latest News
-
Price Band Hitters, September 28, 2026 at 12:00 PM IST: Bliss GVS Pharma, Sunflag, Lalithaa Jewellery, Rehtan TMT
-
Price Band Hitters on September 4, 2026: Bliss GVS Pharma and AksharChem India Lead Price Band Hitters
-
Price Band Hitters on September 4, 2026: Bliss GVS Pharma and AksharChem India Lead Price Band Hitters
-
Price Band Hitters on September 4, 2026 at 12:00 PM: Bliss GVS Pharma Leads Price Band Hitters
-
Bliss GVS Pharma Ltd Stock Hits All-Time High of Rs.447.35 on 3 June 2026
-
Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 440.15
-
Bliss GVS Pharma Ltd Hits All-Time High of Rs 434.35 as Momentum Accelerates
-
Bliss GVS Pharma - Multibaggers: 15 stocks with 25%+ sales and profit growth in Q4 March 2026 - The Economic Times
-
Bliss Gvs Pharma Ltd Latest Corporate Announcements, Blissgvs Latest Company News - BSE
-
Bliss Gvs Pharma Ltd Latest Corporate Announcements, Blissgvs Latest Company News - BSE
Frequently Asked Questions
What is Bliss GVS Pharma's current stock price?
Bliss GVS Pharma shares were last quoted at ₹668.00 (+1.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Bliss GVS Pharma?
Bliss GVS Pharma has a price-to-earnings (P/E) ratio of 55.37 and a price-to-book (P/B) ratio of 6.06. The industry P/E is 53.33.
What is the 52-week high and low of Bliss GVS Pharma?
The 52-week high of Bliss GVS Pharma is ₹733.75 and the 52-week low is ₹118.35.
What is the market cap of Bliss GVS Pharma?
The market capitalisation of Bliss GVS Pharma is about ₹7,542.02 crore.
How did Bliss GVS Pharma perform in its latest quarterly results?
In the latest quarter (Jun 2026), Bliss GVS Pharma reported sales of ₹286.00 crore (+38.2%) and net profit of ₹51.00 crore (+15.9%), compared with the same quarter last year.
Is Bliss GVS Pharma a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Bliss GVS Pharma has a 3-year ROE of 10.00%, 3-year profit growth of 23.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Bliss GVS Pharma?
Promoters hold about 35.01% of Bliss GVS Pharma.
Which sector does Bliss GVS Pharma belong to?
Bliss GVS Pharma belongs to the Pharmaceuticals & Drugs sector.